Niels Ødum portrait

Curriculum Vitae

for Niels Ødum

Department of Immunology and Microbiology
The Mærsk Tower
12th Floor, room 07-12-63
Faculty of Health and Medical Sciences
University of Copenhagen
Blegdamsvej 3
DK-2200 Copenhagen N

+45 28 75 78 79
Cutaneous T cell lymphoma

Cutaneous T cell lymphoma

Read more »

Bacteria fuel cancer

Bacteria fuel cancer

Read more »

miRNA illustration

MicroRNA in inflammation and cancer

Read more »

Cancer inflammation

Malignant Inflammation

Read more »

Academic Examinations, degrees, etc.

YearAcademic Examinations, degrees, etc.
1989D. M.Sc., University of Copenhagen
1982M.D., University of Copenhagen (UC)


2017 - currentIndustrial Ambassador, Department of Immunology and Microbiology
2012Full professorship in immunology, ISIM, Health Science Faculty, University of Copenhagen
2003Full professorship in Signal transduction in the Immune system, Department of Biology University of Copenhagen
1993Associate professor, Inst. Biochem. University of Copenhagen
1992Senior researcher at Dept. for Clinical Immunology, Rigshospitalet
1991Visiting Reseacrh fellow Kyushu University, Fukuoka, Japan
1989Visiting Research fellow Fred Hutchinson Cancer Research, Seattle, USA
1982MD and research fellow at Rigshospitalet, Copenhagen

Research fields of expertice

Cancer immunology

drug development

novel diagnostic biomarkers

T cell lymphomas


signal transduction

immune pathology and therapy




tumor immunology


Publications & Patents

Author of 270 papers in peer-reviewed journals and patents/patent applications within the fields of immunology, immune pathology, signal transduction and gene regulation.

Many publications in high (impact factor > 5) and very high (impact factor > 10) journals including Nature Immunol, Nature Commun, Blood, PNAS, Genes Dev, Cancer Res, Leukemia, and other

Sum of the times cited: > 8000

H-index: 52 (= number of articles cited more than 52 times)

Total number of peer-reviewed publications: > 270

Author of 35 publications, interviews, view-point ect. (not peer reviewed) in news papers and magazines, periodicals, and media like "Ingeniøren", "Ugeskrift for Læger", news and publications from "Kræftens Bekæmpelse", "HøjteknologiFonden", "Danmarks Radio", and other.

Academic and Research Achievements

Made many scientific discoveries including identifying new HLA genes, their function and importance in transplantation and autoimmunity, unravelled Interleukin-2 signal cascades and pathological signalling in T cell lymphoma, discoveries of oncogenes and their targets and functions, diagnostic miRNA profiling of inflammatory skin disorders, identification of novel therapeutic targets, and other discoveries published in more than 270 international peer reviewed journals and patents (cf. above)

Present Project management


managing and financing a research group of 12-14 including associate and assistant professors, post docs and PhD students visiting scientists, as well as graduate students and technicians.

Project manager

Project manager of high-technology, drug and biomarker development, and other projects involving the University of Copenhagen, Exiqon, LEO Pharma, Zealand Pharma, and since January 2016 heading a “tandem-project” bridging basic and clinical health science and supported by the Novo Nordic Foundation, Kræftens Bekæmpelse and other sources with a total budget of 24 mill.


Organizer and leader of an international collaboration on “Identification of novel therapeutic targets in T cell lymphoma” (DK, USA, Canada, Germany, Austria)

Organizer of an international study on “Bacterial toxins in colon inflammation and Cancer” (DK, UK, Italy, Sweden)

Creator of a novel Master Education in Immunology & Inflammation

Instigator and inventor of a novel master education in Immunology and Inflammation at the Health Science Faculty. The education is unique as it is build around a close collaboration between the academic environment at the University and the majority of Pharmeceutical companies in the Greater Copenhagen area. The education was launched from September 2016.

PhD students

14 PhD students including industrial PhDs


Supervised more than 110 master- and PhD students from UC and a series of industrial PhD students from Danish and International pharmaceutical and biotech companies.

Industrial collaboration

Scientific advisor to Mindera Corp (San Francisco, CA) since January 2017. Member of the Scientific Advisory Board at Mindera Corp, a Californian based company developing novel micro-needle devices to human subjects and subsequent analysis by qPCR and RNA-Seq from skin.

Scientific collaboration with Mindera Corp, Novo Nordisk, H-Lundbeck, LEO Pharma, Bioneer, Exiqon, ALK-Abello and Zealand Pharma.

Participated in novel drug discovery and development with Zealand Pharma and other companies.

Ad hoc consultant on patent investigations to Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. New York, USA.

Science administration

Consultant for Human Frontier Science Program, Strasbourg CEDEX, France, Imperial Cancer Research Foundation UK, and the Broad Association (USA). Previous Co-Editor for Exp Clin Immunogen and Advances in Hematology. Reviewer for multiple international journals and organizer/co-organizer of several International conferences. Key-note speaker and chairman of sessions on immune regulation/inflammation/lymphoma at international conferences. Since 2007 Expert assessor and consultant for the Research Council of Norway and ad hoc consultant to the Swedish-, Baltic-, and Dutch- research councils and the Dutch Cancer Research Council. Appointed member of the Danish Research Council – Forskningsrådet for Sundhed og Sygdom (FSS) for a 6 year period from 2013-2019. Member of the FSS executive committee from 2017-2018. From 2018-2022 appointed member of the Scientific Advisory Board (KBVU) for the Danish Cancer Society (Kræftens Bekæmpelse) and other private foundations.

References (2011-2023) in peer-reviewed journals